Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 12

1.

Oral coenzyme Q10 supplementation in patients with migraine: Effects on clinical features and inflammatory markers.

Dahri M, Tarighat-Esfanjani A, Asghari-Jafarabadi M, Hashemilar M.

Nutr Neurosci. 2018 Jan 3:1-9. doi: 10.1080/1028415X.2017.1421039. [Epub ahead of print]

PMID:
29298622
2.

Stroke subtypes, risk factors and mortality rate in northwest of Iran.

Farhoudi M, Mehrvar K, Sadeghi-Bazargani H, Hashemilar M, Seyedi-Vafaee M, Sadeghi-Hokmabad E, Rikhtegar R, Saber-Maroof B, Abutalebi M, Rezaei M, Vaferi S, Aghili A, Ebrahimi O.

Iran J Neurol. 2017 Jul 6;16(3):112-117.

3.

Efficacy of Citalopram on Acute Ischemic Stroke Outcome: A Randomized Clinical Trial.

Savadi Oskouie D, Sharifipour E, Sadeghi Bazargani H, Hashemilar M, Nikanfar M, Ghazanfari Amlashi S, Abbaszade Z, Sadeghihokmabadi E, Rikhtegar R, Golzari SEJ.

Neurorehabil Neural Repair. 2017 Jul;31(7):638-647. doi: 10.1177/1545968317704902. Epub 2017 Apr 28.

PMID:
28454498
4.

Developing Azeri aphasia screening test and preliminary validity and reliability.

Salehi S, Jahan A, Mousavi N, Hashemilar M, Razaghi Z, Moghadam-Salimi M.

Iran J Neurol. 2016 Oct 7;15(4):183-188.

5.

Intravenous recombinant tissue plasminogen activator for acute ischemic stroke: a feasibility and safety study.

Sadeghi-Hokmabadi E, Farhoudi M, Taheraghdam A, Hashemilar M, Savadi-Osguei D, Rikhtegar R, Mehrvar K, Sharifipour E, Youhanaee P, Mirnour R.

Int J Gen Med. 2016 Oct 25;9:361-367. eCollection 2016.

6.

Simple In-Hospital Interventions to Reduce Door-to-CT Time in Acute Stroke.

Sadeghi-Hokmabadi E, Taheraghdam A, Hashemilar M, Rikhtegar R, Mehrvar K, Mehrara M, Mirnour R, Hassasi R, Aliyar H, Farzi M, Hasaneh Tamar S.

Int J Vasc Med. 2016;2016:1656212. doi: 10.1155/2016/1656212. Epub 2016 Jul 10.

7.

Evaluating the status of antiganglioside antibodies in children with Guillain-Barré syndrome.

Hashemilar M, Barzegar M, Nikanfar M, Bonyadi MR, Goldust M, Ramouz A, Ebrahimi F.

Neuroimmunomodulation. 2014;21(1):64-8. doi: 10.1159/000355830. Epub 2013 Nov 20.

PMID:
24280640
8.

The effect of Ginkgo biloba on functional outcome of patients with acute ischemic stroke: a double-blind, placebo-controlled, randomized clinical trial.

Oskouei DS, Rikhtegar R, Hashemilar M, Sadeghi-Bazargani H, Sharifi-Bonab M, Sadeghi-Hokmabadi E, Zarrintan S, Sharifipour E.

J Stroke Cerebrovasc Dis. 2013 Nov;22(8):e557-63. doi: 10.1016/j.jstrokecerebrovasdis.2013.06.010. Epub 2013 Jul 18.

PMID:
23871729
9.

Effect of IMODâ„¢ on the inflammatory process after acute ischemic stroke: a randomized clinical trial.

Farhoudi M, Najafi-Nesheli M, Hashemilar M, Mahmoodpoor A, Sharifipour E, Baradaran B, Taheraghdam A, Savadi-Oskouei D, Sadeghi-Bazargani H, Sadeghi-Hokmabadi E, Akbari H, Rikhtegar R.

Daru. 2013 Mar 20;21(1):26. doi: 10.1186/2008-2231-21-26.

10.

Frequency of microembolic signals in patients with acute ischemic stroke in middle cerebral artery territory treated with aspirin or clopidogrel.

Hashemilar M, Farhoudi M, Hosseini S, Moshayedi H, Savadi Oskoui D, Oghli BE, Rikhtegar R.

Iran J Neurol. 2011;10(1-2):16-8.

11.

Comparison of immunoblotting and ELISA for detection of anti-ganglioside antibodies in children with Guillain-Barre syndrome.

Bonyadi MR, Barzegar M, Badalzadeh R, Hashemilar M.

Iran J Immunol. 2010 Jun;7(2):117-23. doi: IJIv7i2A7.

12.

Varicella-zoster virus reactivation from multiple ganglia: a case report.

Hashemilar M, Ghabili K, Shoja MM, Savadi-Oskouei D, Keyvani H.

J Med Case Rep. 2009 Sep 14;3:9134. doi: 10.4076/1752-1947-3-9134.

Supplemental Content

Loading ...
Support Center